PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Response rate high for some patients with metastatic melanoma treated with vemurafenib

Oral BRAF inhibitor can extend survival to 16 months for some patients

2012-03-19
(Press-News.org) TAMPA, Fla. (March 16, 2012) – An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation. More than 50 percent of the patients in the trial had positive, prolonged responses and a median survival of almost 16 months.

The study was published in a recent issue of the New England Journal of Medicine.

According to study co-author Jeffrey S. Weber, M.D., Ph.D., director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt, approximately 50 percent of melanomas harbor the activating (V600) mutation threonine protein kinase B-RAF. Unfortunately, treatment options for these patients are "limited."

The BRAF inhibitor vemurafenib had been found effective in phase I and phase III trials. However, to determine the overall response rate in previously treated stage IV melanoma patients, the researchers designed a multi-center, phase II trial with 132 patients with previously treated BRAF V600-mutant metastatic melanoma. The trial was designed by senior academic authors and representatives of the trial sponsor, Hoffman-La Roche, and was open to adults over the age of 18 with histologically proven stage IV melanoma, progressive disease, and at least one prior systemic treatment.

"Few patients with metastatic melanoma bearing the BRAF V600 mutation have a response to systemic chemotherapies," said Weber. "Additionally, most have a median survival of only six to 10 months. However, this study yielded an overall response rate of 56 percent and a median survival of nearly 16 months."

The 56 percent response rate for this study was higher than the response rates reported on studies with other therapies for a majority of patients, such as the monoclonal antibody impilimumab. Once more, the response for patients in the vemurafenib phase II trial was "rapid," said the study authors, with less than 15 percent of patients having had disease progression at their first evaluation.

"This trial showed that vemurafenib has clinically evident anti-tumor activity in metastatic melanoma, and that response rates are higher than those associated with previously used treatments," concluded Weber.

The authors reported that toxic effects were common, but not severe or life-threatening in most cases. They added that, as with most targeted therapies that block a driver oconogene, cancer cells can develop resistance with continued dosing and the molecular mechanisms of vemurafenib are "under investigation" at Moffitt by Keiran S. Smalley, Ph.D., and at other institutions to answer questions about resistance.

###

About Moffitt Cancer Center
Follow Moffitt on Facebook: www.facebook.com/MoffittCancerCenter
Follow Moffitt on Twitter: @MoffittNews
Follow Moffitt on YouTube: MoffittNews

Located in Tampa, Moffitt Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center, which recognizes Moffitt's excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt is also a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer.

Media release by Florida Science Communications

END



ELSE PRESS RELEASES FROM THIS DATE:

Nanopills release drugs directly from the inside of cells

2012-03-19
UAB researchers developed a new vehicle to release proteins with therapeutic effects. The vehicles are known as "bacteria inclusion bodies", stable insoluble nanoparticles which are found normally in recombinant bacteria. Even though these inclusion bodies traditionally have been an obstacle in the industrial production of soluble enzymes and biodrugs, they were recently recognised to have large amounts of functional proteins with direct values in industrial and biomedical applications. The research team led by Antoni Villaverde from the Institute of Biotechnology and ...

AGU journal highlights March 16, 2012

2012-03-19
The following highlights summarize research papers that have been recently published in Geophysical Research Letters (GRL), Journal of Geophysical Research-Atmospheres (JGR-D), and Journal of Geophysical Research-Solid Earth (JGR-B). In this release: Measuring mercury in coastal fog water Early Eocene climate warming increased petroleum production Unexpected earthquakes within continental plates pose challenges Land use changes contribute to climate extremes When will warming-induced rainfall changes be perceptible? Model describes New Zealand's complex tectonic ...

New research lowers past estimates of sea-level rise

New research lowers past estimates of sea-level rise
2012-03-19
The seas are creeping higher as the planet warms. But how high could they go? Projections for the year 2100 range from inches to several feet, or even more. The sub-tropical islands of Bermuda and the Bahamas are two seemingly unlikely places scientists have gone looking for answers. The cliffs and ancient reefs on Bermuda and the Bahamas have lured fossil-hunters for decades. The land on the Bahamas, for example, has a foundation of fossil coral; the stone is derived from the disintegration of age-old coral reefs and seashells. These areas are now attracting scientists ...

Torrance Cosmetic Dentist, Dr. Mondavi, is Now Offering New Patients a Dental Implant Specials This Spring

Torrance Cosmetic Dentist, Dr. Mondavi, is Now Offering New Patients a Dental Implant Specials This Spring
2012-03-19
Despite the amazing advances in the field of medicine, many are still suffering from treatable and avoidable oral health conditions. The Center for Disease Control and Prevention's 2011 report on America's overall oral health shows that nearly a quarter of those over the age of 65 have lost all of their teeth due to trauma, gum disease, and tooth decay. This is why the leading Torrance dentist, Dr. Robert Mondavi, is now offering huge discounts to all dental implants this spring for those patients that would like to restore their smile permanently and painlessly. Dental ...

Past in monsoon changes linked to major shifts in Indian civilizations

2012-03-19
A fundamental shift in the Indian monsoon has occurred over the last few millennia, from a steady humid monsoon that favored lush vegetation to extended periods of drought, reports a new study led by researchers at the Woods Hole Oceanographic Institution (WHOI). The study has implications for our understanding of the monsoon's response to climate change. The Indian peninsula sustains over a billion people, yet it lies at the same latitude as the Sahara Desert. Without a monsoon, most of India would be dry and uninhabitable. The ability to predict the timing and amount ...

Who wouldn't pay a penny for a sports car?

2012-03-19
Who wouldn't pay a penny for a sports car? That's the mentality some popular online auctions take advantage of -- the opportunity to get an expensive item for very little money. In a study of hundreds of lowest unique bid auctions, Northwestern University researchers asked a different question: Who wins these auctions, the strategic gambler or the lucky one? The answer is the lucky. But, ironically, it's a lucky person using a winning strategy. The researchers found that all players intuitively use the right strategy, and that turns the auction into a game of pure ...

Environmental factors in Tiny Tim's near fatal illness

2012-03-19
Le Bonheur Professor Russell Chesney, M.D. believes he knows what was ailing Tiny Tim, the iconic character from Charles Dickens' "A Christmas Carol." Based on detailed descriptions of both the symptoms and living conditions of 18th century London, Dr. Chesney hypothesizes that Tiny Tim suffered from a combination of rickets and tuberculosis (TB). His findings were published in the March 5 edition of Archives of Pediatrics and Adolescent Medicine. Dr. Chesney noted during the time the novel was written, 60 percent of children in London had rickets and nearly 50 percent ...

Leading Suit Retailer, Megasuits.com, Releases its Spring Collection with Huge Discounts on all Outfits and Accessories

Leading Suit Retailer, Megasuits.com, Releases its Spring Collection with Huge Discounts on all Outfits and Accessories
2012-03-19
While there is always going to be more to an individual than their appearance, the power of a great outfit can never be underestimated. Those with a perfect look are going to exude confidence in all that they do. For some, this often means a stylish men's suit that complements their personality. This is why Megasuits.com is now offering their spring collection of men's suits at hugely discounted prices for those that would like to look and feel great in the coming months. Purchasing suits has often been a monotonous and expensive chore in the past. Storefronts charged ...

Using virtual worlds to 'soft control' people's movements in the real one

2012-03-19
Eighty-eight percent of Americans now own a cell phone, forming a massive network that offers scientists a wealth of information and an infinite number of new applications. With the help of these phone users — and their devices' cameras, audio recorders, and other features — researchers envision endless possibilities for gathering huge amounts of data, from services that collect user data to monitor noise pollution and air quality to applications that build maps from people's cell phone snapshots. Today, user data provides some opportunities; for example, researchers ...

Obesity raises death risk tied to sleeping pills

2012-03-19
SAN DIEGO -- Obesity appears to significantly increase the risk of death tied to sleeping pills, nearly doubling the rate of mortality even among those prescribed 18 or fewer pills in a year, researchers reported Friday. "Obesity emerged as a marker of increased vulnerability," said Robert Langer, M.D., M.P.H., at the annual American Heart Association's Epidemiology and Prevention | Nutrition, Physical Activity and Metabolism 2012 Scientific Sessions in San Diego. "The associations between sleeping pills and increased mortality were present, and relatively stronger, ...

LAST 30 PRESS RELEASES:

Scientists agree chemicals can affect behavior, but industry workers more reluctant about safety testing

DNA nanospring measures cellular motor power

Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research

Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates

Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches

Catching Alport syndrome through universal age-3 urine screening

Instructions help you remember something better than emotions or a good night’s sleep

Solar energy is now the world’s cheapest source of power, a Surrey study finds

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

Exploring the therapeutic potential of cannabidiol for Alzheimer's

We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity

Seeing double: Clever images open doors for brain research

Inhaler-related greenhouse gas emissions in the US

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

[Press-News.org] Response rate high for some patients with metastatic melanoma treated with vemurafenib
Oral BRAF inhibitor can extend survival to 16 months for some patients